These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27287151)

  • 1. Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo.
    Hari BNV; Narayanan N; Dhevendaran K; Ramyadevi D
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():522-532. PubMed ID: 27287151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine Nanoparticle Laden Polymer Composite Oral Dissolving Films for Improving Therapeutic Potential of the Hydrophobic Antiepileptic Molecule.
    Shankar Raman S; Narayanan VHB; Durai R
    Assay Drug Dev Technol; 2021 Jan; 19(1):2-16. PubMed ID: 33216611
    [No Abstract]   [Full Text] [Related]  

  • 3. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    Kumar P; Lakshmi YS; Kondapi AK
    HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS; Roy K; Choudhary B; Mahadik KR
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies.
    Gaur PK; Mishra S; Bajpai M; Mishra A
    Biomed Res Int; 2014; 2014():363404. PubMed ID: 24967360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy.
    Kumar P; Lakshmi YS; Kondapi AK
    Pharm Res; 2017 Feb; 34(2):257-268. PubMed ID: 27928647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations.
    Chaurasia S; Patel RR; Vure P; Mishra B
    J Pharm Sci; 2018 Feb; 107(2):706-716. PubMed ID: 29031951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering pH-sensitive dissolution of lipid-polymer nanoparticles by Eudragit integration impacts plasmid DNA (pDNA) transfection.
    Santhanes D; Zhang H; Wilkins A; John Aitken R; Gannon AL; Liang M
    Eur J Pharm Biopharm; 2024 Jun; 199():114299. PubMed ID: 38643953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation.
    Kamble RN; Mehta PP; Kumar A
    AAPS PharmSciTech; 2016 Oct; 17(5):1240-7. PubMed ID: 26573159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation.
    McDonald TO; Giardiello M; Martin P; Siccardi M; Liptrott NJ; Smith D; Roberts P; Curley P; Schipani A; Khoo SH; Long J; Foster AJ; Rannard SP; Owen A
    Adv Healthc Mater; 2014 Mar; 3(3):400-11. PubMed ID: 23997027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement.
    Taneja S; Shilpi S; Khatri K
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):978-84. PubMed ID: 25724312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery.
    Ngwuluka NC; Pillay V; Choonara YE; Modi G; Naidoo D; du Toit LC; Kumar P; Ndesendo VM; Khan RA
    Int J Mol Sci; 2011; 12(9):6194-225. PubMed ID: 22016653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid.
    Gargouri M; Sapin A; Bouli S; Becuwe P; Merlin JL; Maincent P
    Technol Cancer Res Treat; 2009 Dec; 8(6):433-44. PubMed ID: 19925027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.
    Gupta S; Kesarla R; Chotai N; Misra A; Omri A
    Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Efavirenz and HIV-1 Fusion Inhibitor Peptide Co-loaded Polymer-Lipid Hybrid Nanoparticles: Statistical Optimization, Cellular Uptake, and
    Surve DH; Jirwankar YB; Dighe VD; Jindal AB
    Mol Pharm; 2020 Oct; 17(10):3990-4003. PubMed ID: 32808785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Eudragit E100/Carbomer 940P interpolyelectrolyte complexes using swellability measurements.
    Kabanova TV; Zhdanova ER; Moustafine RI
    J Control Release; 2006 Nov; 116(2):e33-5. PubMed ID: 17718956
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes.
    Ramyadevi D; Rajan KS; Vedhahari BN; Ruckmani K; Subramanian N
    Colloids Surf B Biointerfaces; 2016 Oct; 146():260-70. PubMed ID: 27351137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
    Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.